PubMed · 6590113
Prolymphocytic leukemia. Serial responses to therapy.
Abstract
Prolymphocytic leukemia is a rare lymphoproliferative disorder characterized by marked lymphocytosis, massive splenomegaly, minimal lymphadenopathy, and poor prognosis. Previous reports have noted very short survival, and poor response to single agent alkylator chemotherapy. A small number of reports have shown response to combination chemotherapy regimens including Adriamycin (doxorubicin). A case of prolymphocytic leukemia with serial responses to combination chemotherapy and splenectomy resulting in significant prolongation of survival is reported.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
J F Swift, H G Wold, D R Gandara, J Redmond, C B George. 1984-09-15. Prolymphocytic leukemia. Serial responses to therapy.. https://doi.org/10.1002/1097-0142(19840915)54%3A6%3C978%3A%3Aaid-cncr2820540605%3E3.0.co%3B2-h
Cite the original work for its findings. Save a collection to share your selection of sources.